2Donato MT, Castell JV. Characterization of drug metabolizing activities in pig hepatocytes for use in bioartificial liver devices: comparison with other hepatic celluer models [J]. J Hepatol, 1999,31 :542 - 549.
3Werner A, Duvar S, Muthing J, et al.Cultivation and characterization of a new immortalizaed human hepatocyte cell lina, HepZ,for the use in an artificial liver support system [ J ]. Ann NY Acad Sci, 1999,18:364 - 368.
4Selden C, Khalil M, Hodgson HJF. what keeps hepatocytes on the straight and narrow. Maintaining differentiated function in the liver[ J ]. Gut, 1999,44:443 --446.
5Wang L, Sun J, Li L, et al. Factors affecting hepatocyte viability and cypiai activity during encapsulation [ J ]. Art Cell Blood Subs Immob Biotech, 2000,28:215 -227.
6Shi Q, Mitteregger R, Falkenhagen D, et al. A novel configuration of bioartificial liver support system based on circulating microcarrier culture[J]. Art Cell Blood Subs Immob Biotech, 2000,28 : 273 -291.
7Flendrig LM, La Soe JW, Joining GG, et al. In vitro evaluation of a novel bioreactor based on an integral oxygenator and a spirally wound nor woveb polyester matrix for hepatocyte culture as small aggregates [ J ]. J Hepatol, 1997,26 : 1397- 1392.
8Ijima H, Nakazawa K, Koyama S, et al.Conditions required for a hybrid artificial liver support system using a PUF/hepatocyte spheroid packed bed module and its use in dogs with liver failure[ J ]. Int J Artif Organs,2000,23:446 -453.
10Robert EA, Letarte M, Squire J, et al.Characterization of human hepatocyte lines derived from normal liver tissue[ J ]. Hepatology, 1994, 19 : 1930 -1399.
